224 related articles for article (PubMed ID: 37369679)
1. K235 acetylation couples with PSPC1 to regulate the m
Zhang XL; Chen XH; Xu B; Chen M; Zhu S; Meng N; Wang JZ; Zhu H; Chen D; Liu JB; Yan GR
Nat Commun; 2023 Jun; 14(1):3815. PubMed ID: 37369679
[TBL] [Abstract][Full Text] [Related]
2. RBM33 is a unique m
Yu F; Zhu AC; Liu S; Gao B; Wang Y; Khudaverdyan N; Yu C; Wu Q; Jiang Y; Song J; Jin L; He C; Qian Z
Mol Cell; 2023 Jun; 83(12):2003-2019.e6. PubMed ID: 37257451
[TBL] [Abstract][Full Text] [Related]
3. ALKBH5-mediated m
Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
[TBL] [Abstract][Full Text] [Related]
4. Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated m
Zhang L; Su X
Cell Oncol (Dordr); 2022 Jun; 45(3):355-365. PubMed ID: 35579750
[TBL] [Abstract][Full Text] [Related]
5. FOXD3-mediated transactivation of ALKBH5 promotes neuropathic pain via m
Huang Z; Zhang Y; Wang S; Qi R; Tao Y; Sun Y; Jiang D; Jiang X; Tao J
Proc Natl Acad Sci U S A; 2024 Feb; 121(6):e2312861121. PubMed ID: 38285939
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
[TBL] [Abstract][Full Text] [Related]
7. EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma.
Lv D; Zhong C; Dixit D; Yang K; Wu Q; Godugu B; Prager BC; Zhao G; Wang X; Xie Q; Bao S; He C; Heiland DH; Rosenfeld MG; Rich JN
Mol Cell; 2023 Dec; 83(23):4334-4351.e7. PubMed ID: 37979586
[TBL] [Abstract][Full Text] [Related]
8. ALKBH5 activates FAK signaling through m6A demethylation in
Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
[No Abstract] [Full Text] [Related]
9. Arginine methylation of ALKBH5 by PRMT6 promotes breast tumorigenesis via LDHA-mediated glycolysis.
Han X; Ren C; Jiang A; Sun Y; Lu J; Ling X; Lu C; Yu Z
Front Med; 2024 Apr; 18(2):344-356. PubMed ID: 38466502
[TBL] [Abstract][Full Text] [Related]
10. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
[TBL] [Abstract][Full Text] [Related]
11. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
[TBL] [Abstract][Full Text] [Related]
12. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
13. ALKBH5 controls the meiosis-coupled mRNA clearance in oocytes by removing the N
Bai L; Xiang Y; Tang M; Liu S; Chen Q; Chen Q; Zhang M; Wan S; Sang Y; Li Q; Wang S; Li Z; Song Y; Hu X; Mao L; Feng G; Cui L; Ye Y; Zhu Y
Nat Commun; 2023 Oct; 14(1):6532. PubMed ID: 37848452
[TBL] [Abstract][Full Text] [Related]
14. Distinct RNA
Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
[TBL] [Abstract][Full Text] [Related]
15. N
Zhu Z; Qian Q; Zhao X; Ma L; Chen P
Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
[TBL] [Abstract][Full Text] [Related]
16. Development of formaldehyde dehydrogenase-coupled assay and antibody-based assays for ALKBH5 activity evaluation.
Shen DD; Suo FZ; Song QM; Chang J; Zhang T; Hong JJ; Zheng YC; Liu HM
J Pharm Biomed Anal; 2019 Jan; 162():9-15. PubMed ID: 30219599
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ALKBH5-mediated m
Guo Y; Song W; Yang Y
Environ Toxicol; 2022 Apr; 37(4):910-924. PubMed ID: 34995009
[TBL] [Abstract][Full Text] [Related]
18. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
[TBL] [Abstract][Full Text] [Related]
19. HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
Huo FC; Zhu ZM; Du WQ; Pan YJ; Jiang X; Kang MJ; Liu BW; Mou J; Pei DS
Pharmacol Res; 2023 Sep; 195():106863. PubMed ID: 37480971
[TBL] [Abstract][Full Text] [Related]
20. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
